Activation of PTGS2/NF‐κB signaling pathway enhances radiation resistance of glioma. (10th February 2019)

• Record Type: Journal Article
• Authors: Tan, Cheng; Liu, Liang; Liu, Xiaoyang; Qi, Ling; Wang, Weiyao; Zhao, Guifang; Wang, Libo; Dai, Yimeng
• Is Part Of: Cancer medicine. Volume 8:Number 3(2019:Mar.)
• Page Start: 1175
• Page End: 1185
• Publication Date: 2019-02-10
• Subjects: glioma -- NF‐κB signaling pathway -- PTGS2 -- radiation resistance; 616.994005
• DOI: 10.1002/cam4.1971
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Objective: We focused on the effects of PTGS2 /NF‐κB signaling pathway on the radiation resistance of glioma in the study. Methods: We downloaded the microarray data from the Gene Expression Omnibus (GEO) database. We verified transfection successfully through QRT‐PCR analysis. Immunofluorescence was used to detect γH2AX content under 2 Gy radiation. The survival rates of cells under 2 Gy irradiation were tested by clonogenic survival assay. Flow cytometry was used to detect cell cycle. Western blot was applied to detect the expression of NF‐κB pathway‐related proteins. We also used MTT assay to detect the proliferation of cells. Results: In this research, we discovered that the expression of the PTGS2 was upregulated in radiation‐resistant glioma cells. The radio‐tolerance rate of U87 cells was obviously elevated after the overexpression of PTGS2 . The radioresistance of U87R cells was significantly reduced after the knockdown of PTGS2 . After radiotherapy, the number of cells arrested in G2/M phase decreased after PTGS2 overexpression in U87cells but increased in PTGS2 knockdown in U87R cells. The survival rate of U87 and U87R cells under radiation decreased significantly after the addition of NF‐κB inhibitor. The proliferation of U87 cells was suppressed by radiation and the addition of Bay 11. In addition, PTGS2 activated NF‐κB signaling pathway and prevented DNA damage after radiotherapy. Lastly, PTGS2 was proved to facilitate tumor cell proliferation and improve the radio‐tolerance. Conclusion: PTGS2 /NF‐κB signaling pathway was involved in radio‐tolerance of glioma cells, which provided a new insight into glioma therapy. Abstract : Our findings have demonstrated that PTGS2 influenced radiotherapy tolerance of U87 cells through the NF‐κB signaling pathway. Importantly, we demonstrated that this pathway promoted the resistance to IR, which was a finding with important therapeutic implications for human glioma.